Shingo Nakamoto Selected Research

Shingo Nakamoto Research Topics

Disease

38	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2009
25	Infections 10/2022 - 10/2010
17	Neoplasms (Cancer) 12/2023 - 10/2008
13	Chronic Hepatitis C 02/2018 - 01/2011
8	Liver Diseases (Liver Disease) 02/2018 - 01/2014
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2013
5	Hepatitis 01/2023 - 01/2014
5	Acute Liver Failure (Fulminant Hepatic Failure) 06/2022 - 05/2013
5	Hepatitis B 05/2016 - 10/2010
5	Chronic Hepatitis B 12/2015 - 09/2011
4	Fibrosis (Cirrhosis) 01/2023 - 05/2015
4	Disease Progression 01/2022 - 01/2009
4	Autoimmune Hepatitis 02/2018 - 09/2015
3	Ascites 04/2024 - 05/2014
3	Hepatic Encephalopathy 04/2024 - 01/2012
3	Inflammation (Inflammations) 01/2023 - 01/2011
3	Non-alcoholic Fatty Liver Disease 10/2022 - 01/2013
3	Hepatitis C 08/2015 - 04/2013
2	Carcinogenesis 06/2023 - 03/2023
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2023 - 09/2015
2	Liver Neoplasms (Liver Cancer) 09/2022 - 11/2021
2	Liver Failure 01/2018 - 01/2016
2	Massive Hepatic Necrosis 02/2017 - 04/2010
2	Hepatitis A (Hepatitis, Infectious) 02/2017 - 01/2014
2	Chemical and Drug Induced Liver Injury 09/2016 - 06/2016
2	Anemia 05/2016 - 01/2012
2	Virus Diseases (Viral Diseases) 05/2015 - 03/2014
1	Portal Hypertension 04/2024
1	Clinical Deterioration 03/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Pulmonary Arterial Hypertension 01/2023
1	Diabetes Mellitus 01/2023
1	Proteinuria 01/2023
1	Acute-On-Chronic Liver Failure 06/2022

Drug/Important Bio-Agent (IBA)

14	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 01/2011
10	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2009
9	InterferonsIBA 09/2020 - 01/2010
7	Sorafenib (BAY 43-9006)FDA Link 07/2023 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2012
5	Bevacizumab (Avastin)FDA Link 12/2023 - 01/2022
5	atezolizumabIBA 12/2023 - 01/2022
5	Endoplasmic Reticulum Chaperone BiPIBA 01/2018 - 01/2014
5	VaccinesIBA 01/2018 - 01/2014
5	entecavir FDA Link 05/2016 - 09/2011
4	lenvatinibIBA 12/2023 - 08/2020
4	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 09/2011
4	Immune Checkpoint InhibitorsIBA 03/2023 - 09/2020
4	CytokinesIBA 01/2023 - 10/2010
4	Biomarkers (Surrogate Marker)IBA 09/2022 - 12/2016
4	SofosbuvirIBA 01/2018 - 01/2016
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 11/2014
4	Alanine Transaminase (SGPT)IBA 05/2015 - 09/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 11/2021
3	Androgen Receptors (Androgen Receptor)IBA 06/2017 - 05/2014
3	Hepatitis B e AntigensIBA 12/2015 - 10/2010
3	Lamivudine (Epivir)FDA Link 01/2013 - 01/2012
2	AlbuminsIBA 04/2024 - 09/2015
2	UNC1999IBA 05/2023 - 11/2021
2	micaIBA 03/2023 - 09/2015
2	regorafenibIBA 01/2020 - 01/2018
2	RNA (Ribonucleic Acid)IBA 03/2018 - 09/2015
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 12/2016
2	Surface Antigens (Surface Antigen)IBA 01/2017 - 09/2015
2	wisteria lectinIBA 01/2017 - 12/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2016 - 09/2015
2	Small Interfering RNA (siRNA)IBA 09/2015 - 05/2014
2	Interferon-betaIBA 05/2015 - 04/2013
2	SimeprevirIBA 05/2015 - 01/2014
2	ThapsigarginIBA 12/2014 - 01/2014
2	Coloring Agents (Dyes)IBA 01/2011 - 10/2008
1	AmmoniaIBA 04/2024
1	cabozantinibIBA 07/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2023
1	RamucirumabIBA 03/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2023
1	LigandsIBA 03/2023
1	MHC class I-related chain AIBA 03/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2023
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	CollagenIBA 01/2023
1	ceramide glucosyltransferaseIBA 01/2023
1	miglustat (Zavesca)FDA Link 01/2023
1	AntigensIBA 10/2022
1	tranilastIBA 10/2022
1	FructoseIBA 10/2022
1	CholesterolIBA 10/2022
1	Cholic AcidIBA 10/2022
1	GelatinIBA 09/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2022

Therapy/Procedure

21	Therapeutics 04/2024 - 01/2009
3	Liver Transplantation 06/2022 - 01/2016
2	Aftercare (After-Treatment) 03/2023 - 01/2017
2	Radiofrequency Ablation 12/2022 - 02/2021
2	Heavy Ion Radiotherapy 12/2022 - 05/2021
2	Retreatment 03/2018 - 01/2018
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2024
1	Punctures 09/2022
1	Precision Medicine 09/2022
1	Immunotherapy 01/2022